PODD Insulet Corporation

Insulet Corporation

Medical/Dental Instruments

Health Care

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.

IPO Year: 2007

Exchange: NASDAQ

Website: insulet.com

Recent Analyst Ratings for Insulet Corporation

Date	Price Target	Rating	Analyst
6/16/2025	$365.00	Buy	Truist
5/30/2025	$380.00	Buy	Goldman
5/13/2025	$350.00	Peer Perform → Outperform	Wolfe Research
4/29/2025		Outperform → Peer Perform	Wolfe Research
3/6/2025	$340.00	Outperform	RBC Capital Mkts
11/6/2024	$300.00	Outperform	Bernstein
5/30/2024	$235.00	Buy	Redburn Atlantic
5/7/2024	$200.00	Peer Perform → Outperform	Wolfe Research
12/21/2023	$180.00 → $238.00	Neutral → Outperform	Robert W. Baird
12/4/2023	$185.00 → $234.00	Equal-Weight → Overweight	Morgan Stanley

See more ratings

Insulet Corporation

Recent Analyst Ratings for Insulet Corporation

Insulet Corporation Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SVP, Global Operations Singh Prem exercised 1,257 shares at a strike of $166.62 and sold $698,216 worth of shares (2,327 units at $300.05), decreasing direct ownership by 21% to 4,143 units (SEC Form 4)

SVP, Chief HR Officer Manea Dan sold $390,065 worth of shares (1,300 units at $300.05), decreasing direct ownership by 13% to 9,090 units (SEC Form 4)

Director Borio Luciana sold $147,056 worth of shares (481 units at $305.73), decreasing direct ownership by 13% to 3,087 units (SEC Form 4)

Director Weatherman Elizabeth H was granted 778 shares, increasing direct ownership by 17% to 5,242 units (SEC Form 4)

Director Stonesifer Timothy C. was granted 778 shares, increasing direct ownership by 27% to 3,629 units (SEC Form 4)

Director Scannell Timothy J was granted 778 shares, increasing direct ownership by 3% to 31,364 units (SEC Form 4)

Director Pease Flavia was granted 778 shares, increasing direct ownership by 27% to 3,629 units (SEC Form 4)

Director Minogue Michael R was granted 778 shares, increasing direct ownership by 56% to 2,158 units (SEC Form 4)

Director Hopfield Jessica was granted 778 shares, increasing direct ownership by 3% to 27,695 units (SEC Form 4)

Director Frederick Wayne A.I. was granted 778 shares, increasing direct ownership by 24% to 4,009 units (SEC Form 4)